Retinoic acids in the treatment of most lethal solid cancers

L Costantini, R Molinari, B Farinon… - Journal of clinical …, 2020 - mdpi.com
Although the use of oral administration of pharmacological all-trans retinoic acid (ATRA)
concentration in acute promyelocytic leukaemia (APL) patients was approved for over 20 …

[HTML][HTML] The emerging roles of GPRC5A in diseases

H Zhou, I Rigoutsos - Oncoscience, 2014 - ncbi.nlm.nih.gov
Abstract The 'Retinoic Acid-Inducible G-protein-coupled receptors' or RAIG are a group
comprising the four orphan receptors GPRC5A, GPRC5B, GPRC5C and GPRC5D. As the …

[PDF][PDF] Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in …

L Badea, V Herlea, SO Dima, T Dumitrascu… - Hepato …, 2008 - ai.ici.ro
Background: The precise details of pancreatic ductal adenocarcinoma (PDAC)
pathogenesis are still insufficiently known, requiring the use of higthroughput methods …

Isolation and identification of potential urinary microparticle biomarkers of bladder cancer

DM Smalley, NE Sheman, K Nelson… - Journal of proteome …, 2008 - ACS Publications
Bladder cancer leads to approximately 13 000 deaths annually in the United States. Early
disease is often treated with minimal morbidity and has good prognosis, while the opposite …

Phosphosignature predicts dasatinib response in non-small cell lung cancer

M Klammer, M Kaminski, A Zedler, F Oppermann… - Molecular & Cellular …, 2012 - ASBMB
Targeted drugs are less toxic than traditional chemotherapeutic therapies; however, the
proportion of patients that benefit from these drugs is often smaller. A marker that confidently …

Adaptive RSK‐EphA2‐GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer

L Moyano‐Galceran, EA Pietilä, SP Turunen… - EMBO molecular …, 2020 - embopress.org
Metastatic cancers commonly activate adaptive chemotherapy resistance, attributed to both
microenvironment‐dependent phenotypic plasticity and genetic characteristics of cancer …

Epigenetic Silencing of the Candidate Tumor Suppressor Gene Per1 in Non–Small Cell Lung Cancer

S Gery, N Komatsu, N Kawamata, CW Miller… - Clinical cancer …, 2007 - AACR
Purpose: Epigenetic events are a critical factor contributing to cancer development. The
purpose of this study was to identify tumor suppressor genes silenced by DNA methylation …

Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts

S Esseghir, JS Reis‐Filho, A Kennedy… - The Journal of …, 2006 - Wiley Online Library
This study demonstrates, through a combination of stringent screening methods and
thorough validation, that it is possible to identify transmembrane proteins preferentially …

Identification of the retinoic acid–inducible Gprc5a as a new lung tumor suppressor gene

Q Tao, J Fujimoto, T Men, X Ye, J Deng… - JNCI: Journal of the …, 2007 - academic.oup.com
Background Lung cancers develop via multiple genetic and epigenetic changes, including
inactivation of tumor suppressor genes. We previously cloned human G protein–coupled …

Lung tumor suppressor GPRC5A binds EGFR and restrains its effector signaling

S Zhong, H Yin, Y Liao, F Yao, Q Li, J Zhang, H Jiao… - Cancer research, 2015 - AACR
Abstract GPRC5A is a G-protein–coupled receptor expressed in lung tissue but repressed in
most human lung cancers. Studies in Gprc5a−/− mice have established its role as a tumor …